New drug combo shows promise in brain cancer battle

This early-phase trial tests a new drug called selinexor alongside standard radiation and chemotherapy for people with newly diagnosed glioblastoma, a fast-growing brain cancer. The main goal is to find the highest safe dose of selinexor that can be given with these treatments. About 11 adults will take part, taking selinexor pills once a week during radiation and chemo, with regular checkups and scans to monitor safety and tumor response.